These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31057686)

  • 1. Gallbladder Paraganglioma Associated with
    Abdul Sater Z; Jha A; Mandl A; Mangelen SK; Carrasquillo JA; Ling A; Gonzales MK; Lopes Abath Neto O; Miettinen M; Adams KT; Nockel P; El Lakis M; Pacak K
    Nucl Med Mol Imaging; 2019 Apr; 53(2):144-147. PubMed ID: 31057686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.
    Janssen I; Blanchet EM; Adams K; Chen CC; Millo CM; Herscovitch P; Taieb D; Kebebew E; Lehnert H; Fojo AT; Pacak K
    Clin Cancer Res; 2015 Sep; 21(17):3888-95. PubMed ID: 25873086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, Diagnostic, and Treatment Characteristics of
    Jha A; de Luna K; Balili CA; Millo C; Paraiso CA; Ling A; Gonzales MK; Viana B; Alrezk R; Adams KT; Tena I; Chen A; Neuzil J; Raygada M; Kebebew E; Taieb D; O'Dorisio MS; O'Dorisio T; Civelek AC; Stratakis CA; Mercado-Asis L; Pacak K
    Front Oncol; 2019; 9():53. PubMed ID: 30854332
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.
    Gabriel S; Blanchet EM; Sebag F; Chen CC; Fakhry N; Deveze A; Barlier A; Morange I; Pacak K; Taïeb D
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):170-7. PubMed ID: 23230826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
    Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
    Janssen I; Chen CC; Taieb D; Patronas NJ; Millo CM; Adams KT; Nambuba J; Herscovitch P; Sadowski SM; Fojo AT; Buchmann I; Kebebew E; Pacak K
    J Nucl Med; 2016 Feb; 57(2):186-91. PubMed ID: 26564322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
    Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
    Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of FDG-PET imaging in screening for succinate dehydrogenase B and D mutation-related lesions.
    Kornaczewski ER; Pointon OP; Burgess JR
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):172-9. PubMed ID: 26776272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Paraganglioma: A Rare Manifestation of Paraganglioma Syndrome Associated With Pathogenic Variant in
    Tarasova VD; Samuel K; McMullen C; Kushchayev S; Hernandez Prera JC; Veloski C
    JCEM Case Rep; 2024 Sep; 2(9):luae135. PubMed ID: 39156002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
    Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
    Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Tosunoğlu Z; Baykal Koca S; Ergül N; Çermik TF; Arsla E
    Mol Imaging Radionucl Ther; 2024 Oct; 33(3):182-184. PubMed ID: 39373189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.
    Lepoutre-Lussey C; Caramella C; Bidault F; Déandreis D; Berdelou A; Al Ghuzlan A; Hartl D; Borget I; Gimenez-Roqueplo AP; Dumont F; Deschamps F; Nascimento C; Lumbroso J; Guillaud Bataille M; Schlumberger M; Baudin E; Leboulleux S
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):868-76. PubMed ID: 25676472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.
    Tepede AA; Welch J; Lee M; Mandl A; Agarwal SK; Nilubol N; Patel D; Cochran C; Simonds WF; Weinstein LS; Jha A; Millo C; Pacak K; Blau JE
    Endocrinol Diabetes Metab Case Rep; 2020 Mar; 2020():. PubMed ID: 32130200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative
    Amodru V; Guerin C; Delcourt S; Romanet P; Loundou A; Viana B; Brue T; Castinetti F; Sebag F; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):278-282. PubMed ID: 28918451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performances of Functional and Anatomic Imaging Modalities in
    Patel M; Jha A; Ling A; Chen CC; Millo C; Kuo MJM; Nazari MA; Talvacchio S; Charles K; Miettinen M; Del Rivero J; Chen AP; Nilubol N; Lin FI; Civelek AC; Taïeb D; Carrasquillo JA; Pacak K
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of chromogranin A in SDHx-related paragangliomas.
    Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
    Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of chromogranin A for the surveillance of succinate dehydrogenase B- and succinate dehydrogenase D-related paraganglioma.
    Thompson MJ; Parameswaran V; Burgess JR
    Ann Clin Biochem; 2019 Jan; 56(1):163-169. PubMed ID: 30373390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.
    Marzola MC; Chondrogiannis S; Grassetto G; Rampin L; Maffione AM; Ferretti A; Opocher G; Schiavi F; Colletti PM; Rubello D
    Clin Nucl Med; 2014 Jan; 39(1):e53-8. PubMed ID: 23856824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Performance of (68)Ga-DOTATATE PET/CT, (18)F-FDG PET/CT and (131)I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma.
    Tan TH; Hussein Z; Saad FF; Shuaib IL
    Nucl Med Mol Imaging; 2015 Jun; 49(2):143-51. PubMed ID: 26085860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.